Shares of Spherix Inc. soared 21% in active morning trading Friday, after the biotechnology company said it executed an exclusive option agreement with the University of Maryland, Baltimore for the technology in the patent for "Methods of Treating Coronavirus Infection." Trading volume swelled to 2.2 million shares, already more than the full-day average of 1.2 million shares. The company said the invention was made with support awarded by the National Institutes of Health, which has certain rights in the invention. Under terms of the option, Spherix said it has until the end of May to execute a license agreement for commercial development. The stock has lost 23% over the past three months, while the iShares Nasdaq Biotechnology ETF has slipped 2.5% and the S&P 500 has shed 6.9%.
México Últimas Noticias, México Titulares
Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.
Mainland China reports 139 new coronavirus casesMainland China had 139 new confirmed cases of coronavirus infections on Wednesda...
Leer más »
California declares emergency over coronavirus as death toll rises in U.S.California Governor Gavin Newsom declared a statewide emergency in response to the coronavirus
Leer más »
COVID-19 epidemic can be pushed back with concerted approach: WHOThe epidemic of COVID-19 coronavirus infection spreading around the world can be contained and controlled, the WHO said, but only with a concerted response by all governments
Leer más »
Cases in China slow as global infections approach 100,000Cases of coronavirus in China slow as global infections approach 100,000.
Leer más »
Coronavirus infections jump to 82 in the Netherlands: RIVMThe number of patients infected with the coronavirus in the Netherlands has more...
Leer más »